Fundraising Fox

Sharon Shacham

Investor

Managing Partner at E44 Ventures

Tel Aviv, Israel

Writes $1M – $5M checks · typically $2M

About

PhD and MBA holder serving as Managing Partner at E44 Ventures.

Experience

  1. E44 VenturesCo-Founder and Managing Directorcurrent2022 — presentTel Aviv, Israel
  2. phelasAdvisory Boardcurrent2023 — present
  3. GigablueBoard Observercurrent2023 — present
  4. CarbonadeBoard Observercurrent2023 — present
  5. AgriPassBoard Membercurrent2023 — present
  6. Karyopharm Therapeutics Inc.Foundercurrent2009 — present
  7. Karyopharm Therapeutics Inc.Scientific Advisory Board Membercurrent2009 — present
  8. Karyopharm Therapeutics Inc.Chief Scientific Officer2021 — 2022Newton, Massachusetts, United States
  9. Karyopharm Therapeutics Inc.President and CSO2011 — 2021Newton, Massachusetts, United States
  10. Karyopharm Therapeutics Inc.CEO and President2009 — 2011
  11. Sporos BioventuresScientific and Clinical Advisorcurrent2021 — present
  12. Acrivon Therapeutics, Inc.Board Membercurrent2021 — present
  13. Merlin HealthBoard Membercurrent2021 — present
  14. ProtaiScientific Advisorcurrent2022 — present
  15. Polaroid TherapeuticsCo-Founder2021 — 2022Zurich, Switzerland
  16. EPIX PharmaceuticalsSVP Drug Development2000 — 2009
  17. Predix PharmaceuticalsDirector, Algorithm and Software Development2000 — 2003

Education

  1. Tel Aviv UniversityPhD, Biochemistry and Computational Biophysics1995 — 2000
  2. Tel Aviv UniversityMBA, Information Systems1997 — 2000

Colleagues at E44 Ventures

Adi Vagman
Managing Partner at E44 Ventures
Anat Haas Mizrahi
Managing Partner at E44 Ventures
Eli Waxman
Scientific Partner at E44 Ventures
Israel Bar Joseph
Scientific Partner at E44 Ventures
Udi Netzer
Scientific Partner at E44 Ventures

Frequently asked questions

Where does Sharon Shacham work?
Sharon Shacham is Managing Partner at E44 Ventures.
What check size does Sharon Shacham write?
Sharon Shacham typically writes checks of $1M – $5M.

Same school

Also attended Tel Aviv University375

Matan RoetAssociate at Redpoint VenturesArnon DinurPartner at 83NorthYoram SnirPartner at 83NorthDavid GoldschmidtManaging Director, Head of the Fund at Samsung Catalyst FundAmit ShofarSr. Investment Director at Samsung Catalyst FundRutie AdarInvestments & Innovation Sr. Director, Israel at Samsung Catalyst Fund

+ 369 more

Shared employers

Also worked at phelas1

Harry GilbertInvestor at bp ventures

Also worked at Karyopharm Therapeutics Inc.3

Ari ShamissCo-Founder, Managing General Partner at ALIVE Israel HealthTech FundDeepa PakianathanGeneral Partner at Delphi VenturesAnat Haas MizrahiManaging Partner at E44 Ventures

Also worked at Sporos Bioventures1

Jeno GyurisPartner at Cure Ventures

Also worked at Acrivon Therapeutics, Inc.2

Nathan DavisAnalyst at RA CapitalDerek DiRoccoPartner at RA Capital